Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]DPA-714 PET for Glioma Grading
NCT05672082Withdrawn
- Sponsor
- Centre Eugène Marquis
- Start
- Oct 2023
- Primary completion
- Mar 2025
01
Overview
Open-label, single-arm trial, sponsored by Centre Eugène Marquis. Primary endpoint: Diagnostic performances of [18F]DPA-714 PET for glioma grading obtained by stereotactic biopsies of glioma. Planned start Oct 2023; status: withdrawn.
Beyond the preview
Go deeper on NCT05672082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05672082.